DEC 16, 2017 08:33 AM PST
Memory T Cells Having Surprising Extra Role in Immunity
WRITTEN BY: Kara Marker
4 6 411

Long-term immune protection isn’t the only job tasked to memory T cells, researchers are finding. In a new collaborative study between St. Jude Children’s Research Hospital and Emory University’s School of Medicine, scientists investigate the origin of memory CD8 T cells for the purpose of learning to manipulate these cells for improving vaccines and cancer immunotherapies, and the answer contradicts their previous beliefs.

Ben Youngblood, Ph.D., pictured with Hazem Ghoneim, Ph.D., and colleagues showed how memory CD8 T cells arise from a small subset of effector CD8 T cells in laboratory models. Credit: Seth Dixon/St. Jude Children's Research Hospital

The difference between effector CD8 T cells and memory CD8 T cells is activity. Effector cells go to work fighting viruses, cancer, and other things while memory cells hang back, circulating in the blood. These memory cells “remember” viruses from an initial infection in the body, and they are prepared to respond if they come back.

Scientists previously believed that effector and memory CD8 T cells differentiated from naive T cells as completely different distinct lineages, but the new study shows that this is not the case.

Using a mice model of viral infection, researchers found that memory CD8 T cells differentiate from a small subset of effector CD8 T cells, not directly from naive T cells. They used a slew of epigenetic and gene expression information from next-generation whole genome bisulfide sequencing to determine this.

“Memory CD8 T cells arise from effector CD8 T cells and, in fact, must transit through an effector stage of differentiation before becoming memory cells," explained first author Ben Youngblood, PhD.

Indeed, although effector cells that become memory CD8 T cells undergo demethylation, which alters gene expression that facilitates the transition, memory CD8 T cells derived from effector cells hold on to their effector T cell methylation patterns, which enables them to continue responding to active infections while acting as a memory cell.

In the future, Youngblood and others plan on learning how to use their new understanding of the origin of memory CD8 T cells to improve personalized immunotherapies designed to recognize and target specific tumors.

The present study was published in the journal Nature.

Source: St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 20, 2018
Immunology
MAR 20, 2018
Heart Failure from Pressure Overload is Preventable
Heart failure that ultimately results from disease factors like high blood pressure can be predicted and potentially prevented. In a new University of Alab
APR 06, 2018
Clinical & Molecular DX
APR 06, 2018
New Diagnostic Test for Lyme Disease
Diagnostic tests for Lyme disease, or Lyme neuroborreliosis (LNB) can take up to a week, but patients affected need antibiotics as soon as possible to prev
MAY 16, 2018
Immunology
MAY 16, 2018
Antibodies Neutralize Two Different Hemorrhagic Fever Viruses
Scientists have found evidence for potential antibody-based therapeutics to treat more than one hemorrhagic fever virus at once. From Harvard Medical Schoo
JUN 13, 2018
Health & Medicine
JUN 13, 2018
Insurance Denials Prevent Patients From Getting Hep C Medication
Some ads are running on television and in major magazines about drugs for hepatitis C, known as Hep C or HCV. Available in the United States since 2014, th
JUL 05, 2018
Health & Medicine
JUL 05, 2018
Is Testing Everyone for Hep C Necessary?
Cases of Hepatitis C, known as Hep C or HCV, are on the rise. In the United States, the CDC reports that there were approximately 3,000 new cases of hepati
JUL 11, 2018
Immunology
JUL 11, 2018
The Power of Seal Serum
Unlike humans, seals remain uninjured despite repeated deep dives to hunt. Scientists have shown that serum from seals blood provides anti-inflammatory properties that lower immune response.
Loading Comments...